Activity : High-efficiency turbo blower technology to the water and wastewater treatment market in North America and Europe
Sector : Industrials
Acquired by: Export Development Canada
Transaction Type: Sell-side
What our clients say
“This has been a highly complex transaction involving 10 jurisdictions. Cavendish has held our hands throughout the process, providing a dedicated team who have done a superb job; this has greatly reduced interruptions to our businesses whilst adhering to the original timetable. Cavendish has achieved a very successful sale at a fair price to a buyer who will enjoy significant strategic value...
Michael Bostelmann | Group Managing Director of Fandstan Electric Group
“Cavendish played an invaluable role throughout a complex transaction and in particular getting the transaction across the finishing...
Lee Mowle|Owner and CEO of Stewarts
“This deal provides an excellent platform for the Levolux business to continue its overseas expansion. As well as the compelling strategic fit, Alumasc provides an excellent home for the Levolux brand and team. We are delighted with the outcome and the support extended to us by...
John Stern|Chairman, Levolux
The owner of APG-Neuros, a company based in Québec, Canada, has sold an equity position to the Private Equity division of Export Development Canada (EDC).
APG-Neuros is recognized as the force behind the successful introduction of the high-efficiency turbo blower technology to the water and wastewater treatment market in North America, Europe and the Middle-East, modernizing an aging industry. APG-Neuros cleantech turbo blowers are used in a variety of industrial applications and wastewater treatment processes, with over 5,000 units installed worldwide.
EDC is a financial crown corporation dedicated to supporting and developing Canada’s export trade. It is a self-financing institution that operates independently from the government. Since 2012, EDC has facilitated more than US$6 billion in cleantech business in 114 countries. EDC’s investment team manage an investment portfolio in Canadian and international companies and funds with aggregate commitments totaling approximately US$2 billion. Its direct investment in private companies provides a patient capital solution to business owners to help support organic growth and/or acquisition initiatives.
Oaklins’ team in Canada acted as advisor to the seller and the management team of APG-Neuros in the preparation of the sale process and due diligence, the approach and parallel negotiations with potential buyers, and assisted them until closing.